StonvexLoading…
StonvexStonvexStonvexCore line items from FND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-25 | Annual 2024 2024-12-26 | Annual 2023 2023-12-28 | Annual 2023 2023-09-28 |
|---|---|---|---|---|
Revenue | $4.68B | $4.46B | $4.41B | $1.11B |
Operating Income | $270.07M | $256.18M | $321.43M | Not available |
Net Income | $208.65M | $205.87M | $245.98M | $65.92M |
EPS (Diluted) | $1.92 | $1.90 | $2.28 | $0.61 |
Total Assets | $5.47B | $5.05B | $4.66B | Not available |
Total Liabilities | $3.06B | $2.88B | $2.73B | Not available |
Cash & Equivalents | $249.30M | $187.67M | $34.38M | Not available |
Free Cash Flow OCF − CapEx | $64.07M | $156.33M | $255.98M | Not available |
Shares Outstanding | 107.77M | 107.36M | 106.74M | Not available |